Capsules: the most standardised route

TL;DR

• Behaves like an edible: slow onset, long 11-OH-THC peak.
• Exactly reproducible dose – critical for medical use.
• In Switzerland outside studies: FOPH exceptional authorisation needed.
• Compliance win: once-daily dosing is easier to sustain.

Role in Swiss medicine

Since August 2022, Swiss physicians can prescribe medical cannabis without an individual FOPH authorisation (NarcA revision). Standardised capsules (dronabinol, whole-plant preparations) allow 2.5 mg titration – see MacCallum/Russo 2018.

Capsules: standard dose instead of estimation

From a pharmaceutical perspective, capsules are the cleanest oral route: the content is pre-filled, the strength per unit is declared, and the dose is identical from day to day. This makes them attractive for regular use — especially for CBD, where experience shows that a consistent daily dose over weeks is more beneficial than a single high dose. Soft gelatine capsules with an oil filling absorb cannabinoids better than powder capsules.

Pharmacokinetically, capsules behave like edibles: onset of action after 30 to 120 minutes, peak after two to four hours, duration six to twelve hours. Here, too, the first-pass effect applies, with the formation of 11-hydroxy-THC in THC-containing products. Taking the capsule with a high-fat meal significantly increases absorption and makes it more consistent at the same time.

• Exact, reproducible dose per unit
• Timeline identical to edibles: 30–120 min until onset of action
• Oil or soft gelatine capsules are more easily absorbed than powder
• Take with a high-fat meal

Status in Switzerland and interactions

In Switzerland, CBD capsules are usually not marketed as food, but as food supplements or aroma products, because foods containing cannabinoids require BLV authorization as novel foods. Interactions are medically relevant: CBD inhibits certain cytochrome P450 enzymes and can thereby alter the blood levels of other medications — such as blood thinners or antiepileptics. Anyone taking medication regularly should clarify the combination with a doctor beforehand.

Swiss classification: Products with less than 1% total THC (THC + THCA × 0.877) are not narcotics and are freely available; above this, the Narcotics Act applies. For road traffic, the method of consumption is irrelevant — the decisive factor is the detection limit value of 1.5 µg THC per litre of blood, which leads to unfitness to drive. Medical cannabis has been prescribable by doctors without an exceptional permit from the BAG since August 2022.

Galenic differences and quality characteristics

The production of cannabis capsules requires precise pharmaceutical processes to guarantee a uniform distribution of the active ingredients. A fundamental distinction is made between soft gelatine capsules, which are usually filled with an oily solution, and hard capsules, which contain powdered plant extracts or isolates. These galenic differences play a decisive role in absorption by the human body. Oily preparations promote the solubility of lipophilic cannabinoids and also protect the sensitive substances from oxidation by atmospheric oxygen. Hard capsules, on the other hand, often offer the advantage of a purely plant-based shell, which is relevant for individuals following a vegan lifestyle.

A key quality factor in production is the stability of the capsule shell against the liquid content. High-quality preparations use special carrier oils such as medium-chain triglycerides, which not only extend the shelf life but also survive the passage through the stomach undamaged. Inferior products tend to leak prematurely or release active ingredients unevenly. For consumers, it is therefore advisable to look for certified manufacturing processes in which every batch is laboratory-tested for purity, heavy metals, and exact active ingredient content to rule out unwanted contamination.

• Distinction between oily soft gelatine capsules and powder-based hard capsules for different needs.
• Use of stable carrier oils to increase shelf life and protect against oxidation.
• Importance of certified laboratory analyses to ensure purity and exact distribution of active ingredients.
• Vegan alternatives through cellulose-based hard capsule shells instead of animal gelatine.

Practice of intake and increasing bioavailability

The absorption of cannabinoids via the gastrointestinal tract is naturally limited because these compounds are fat-soluble. To optimize the bioavailability of the capsules, it is recommended to take them together with a high-fat meal or a corresponding drink. Lipids in the chyme stimulate the secretion of bile salts, which encapsulate the cannabinoids in tiny micelles. This allows the active ingredients to pass through the intestinal wall much more efficiently and enter the bloodstream in larger quantities. Without this fat accompaniment, a significant portion of the active ingredients is excreted unused.

Another important aspect is the timing of intake in daily life. Since the effect only sets in after passing through the stomach and the subsequent passage through the liver, users must be patient and must under no circumstances prematurely take a second dose. Common mistakes such as taking them on an empty stomach can also lead to mild stomach upsets. By structured logging of intake times and accompanying meals, the individual effect in daily life can be precisely controlled and adapted to personal needs without unexpected fluctuations in intensity.

• Intake always in conjunction with healthy fats to significantly increase active ingredient absorption.
• Avoidance of premature redosing by taking into account the delayed gastrointestinal passage.
• Protection of the gastric mucosa by avoiding intake on a completely empty stomach.
• Keeping an intake diary to determine the optimal timing in the individual daily routine.

Distinction from tinctures and classic edibles

Although capsules, tinctures, and edible cannabis products such as cookies or gummy bears are all consumed orally, they differ in key aspects. Classic edibles often exhibit an irregular distribution of active ingredients and usually contain sugar or other additives that are unsuitable for long-term medical use. Capsules, on the other hand, offer an absolutely taste-neutral alternative without unnecessary calories. Compared to baked goods, they have an extremely long shelf life and barely change their chemical composition when stored correctly. This makes them a discreet and reliable option for everyday use.

Compared to tinctures or oils, which are administered sublingually under the tongue, capsules bypass direct absorption via the oral mucosa. While this allows tinctures to take effect somewhat faster, capsules score points with unsurpassed discretion when used in public. There is no need to measure drops, and there is no risk of spilling. For individuals who dislike the intense, often bitter inherent taste of hemp extracts, capsules represent the cleanest and most convenient method to ingest standardized amounts of cannabinoids without any taste impairment.

• Absolute taste neutrality compared to bitter oils or heavily flavored tinctures.
• Avoidance of sugar, allergens, and unnecessary calories, as found in classic edibles.
• Longer shelf life and higher chemical stability due to the airtight enclosure within the capsule shell.
• Maximum discretion when used on the go, without the need to measure drops.

Procurement channels and legal framework in Switzerland

In Switzerland, access to cannabis capsules is strictly regulated and depends primarily on the THC content. Products with a total THC content of less than one percent are not considered narcotics and are commercially available as food supplements or cosmetics, provided they meet the guidelines of the Federal Food Safety and Veterinary Office (FSVO). For capsules with a higher THC content, the Narcotics Act applies. Since the amendment of the law in August 2022, Swiss physicians can prescribe such high-strength medical capsules directly on prescription, without the need to obtain a tedious exceptional authorization from the Federal Office of Public Health (FOPH).

The dispensing of these prescription-only preparations takes place exclusively through specialized pharmacies that dispense magistral formulations or approved finished medicinal products. In parallel, the scientific pilot trials in various Swiss cities such as Zürich or Basel offer another legal option for obtaining regulated cannabis products, with the focus here being on recreational use under scientific supervision. Consumers should note that a strict zero-tolerance policy applies to road traffic. Even the smallest traces of THC in the blood lead to an inability to drive, which is why driving vehicles must be avoided after taking capsules containing THC.

• Free purchase of capsules with less than one percent total THC in accordance with Swiss guidelines.
• Direct medical prescription requirement for THC-rich capsules in pharmacies since August 2022.
• Sourcing options within the framework of cantonal pilot trials for the scientific study of consumption.
• Strict compliance with the limit of 1.5 micrograms of THC per litre of blood in Swiss road traffic.

FAQ